ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1164508 BOSTON, MA

Position in ACAD

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$49,826,958

+$14,890,089 QoQ

Shares Held

1,969,445

+25.5% QoQ

Ownership

1.14%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#15

of 354 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $2,515,799,583 across 71 Biotechnology names. ACAD ranks #13 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	738,378	$366,774,503
2	INCY	Incyte Corp	2,744,958	$311,168,438
3	REGN	Regeneron Pharmaceuticals, Inc.	393,685	$245,478,344
4	EXEL	Exelixis, Inc.	4,365,926	$237,550,033
5	GMAB	Genmab A/S	4,975,324	$136,672,150
6	RPRX	Royalty Pharma plc	2,435,341	$136,549,569
7	HALO	Halozyme Therapeutics, Inc.	1,704,623	$133,420,842
8	ONC	BeOne Medicines Ltd.	249,758	$71,173,537

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$49,826,958	1,969,445	+25.5%	Shares	Defined	2026-08-13
2026-03-31	$34,936,869	1,569,491	+4.5%	Shares	Defined	2026-05-14
2025-12-31	$40,134,900	1,502,617	-8.9%	Shares	Defined	2026-02-13
2025-09-30	$35,186,757	1,648,864	+390.1%	Shares	Defined	2025-11-13
2025-06-30	$7,256,967	336,438	+512.8%	Shares	Defined	2025-08-13
2023-09-30	$1,144,136	54,901	-10.1%	Shares	Defined	2023-11-14
2022-06-30	$860,884	61,099	+901.6%	Shares	Defined	2022-08-15
2020-12-31	$326,106	6,100	-95.8%	Shares	Defined	2021-02-12
2020-09-30	$5,930,141	143,761	-49.8%	Shares	Defined	2020-11-12
2020-06-30	$13,868,914	286,134	+767.1%	Shares	Defined	2020-08-12
2020-03-31	$1,394,250	33,000	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.